Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02324894

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Accepted

Summary

Mammography remains an imperfect screening test especially in women with extremely dense breast tissue, missing biologically aggressive cancers especially in younger population and picking up indolent cancers that do not need treatment. The most sensitive test for breast cancer detection at our disposal is magnetic resonance imaging (MRI). The preliminary study of Dr Kuhl provide strong arguments that Ultra FAST Breast Magnetic Resonance is suitable for breast cancer screening with high sensitivity and specificity values. Data clearly demonstrates that FAST breast MRI could be the standard for breast cancer screening: it is safe, does not induce cancers, and can find more cancers than mammography. However this study was performed in women with low to moderately increased risk.The value of FAST Breast Magnetic Resonance in normal screening population has to be assessed before a modification of current strategy of breast cancer screening with mammography.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRI screeningDiagnostic screening. The normal eligible screening population will first undergo a mammography, then an echography screening followed by a fast MRI screening.

Timeline

Start date
2015-01-01
Primary completion
2019-04-16
Completion
2019-04-16
First posted
2014-12-24
Last updated
2019-04-17

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02324894. Inclusion in this directory is not an endorsement.